Risk factor
Poor trading liquidity
Profitability factor
Very strong margins and returns
About
Cipher Pharmaceuticals Inc. operates as a specialty pharmaceutical company in Canada. Its commercial products include Epuris (CIP-ISOTRETINOIN), a formulation of the active ingredient isotretinoin for use in the treatment of severe acne; Ozenoxacin to treat adult and paediatric patients with impetigo; Actikerall, which is indicated for the treatment of palpable or moderately thick hyperkeratotic actinic...
Company Valuation
Based on key historical and expected multiples, the stock is fairly valued relative to its peers. Specifically, the stock is fairly valued on P/E, neutral on EV/EBITDA, u
Target Price
The average target price of CPH.TO is 20 and suggests 34% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to increa
Buy
Sell